In addition, safety evaluations showed no observed cardiotoxicity or hepatotoxicity in the combination therapy group, indicating the safety and efficacy of NK cells combined with rAd.DCN in the treatment of colon cancer. The gene discussed is DCN; the disease is malignant colon neoplasm.